I. Royston

发表

Applications of monoclonal antibodies in cancer therapy.

R. Dillman, I. Royston, 1984, British medical bulletin.

2nd PEGS Annual Symposium on Antibodies for Cancer Therapy

Mitchell Ho, A. Beck, I. Royston, 2012, mAbs.

EPSTEIN-BARR VIRUS AND INFECTIOUS MONONUCLEOSIS

I. Royston, 1973 .

A Novel Monoclonal Antibody-defined Antigen Which Distinguishes Human Non-Small Cell from Small Cell Lung Carcinomas 1

Douglas, D. Carlo, Christopher, 2006 .

Carcinomas Distinguishes Human Non-Small Cell from Small Cell Lung A Novel Monoclonal Antibody-defined Antigen Which Updated

Douglas, D. Carlo, Christopher, 2006 .

Gene therapy approaches to enhance antitumor immunity.

D. Mercola, C. V. van Beveren, D. Gold, 1997, Advances in pharmacology.

Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.

I. Royston, S. Baird, J. C. Griffiths, 1980, Journal of immunology.

Induction of in vitro and in vivo antigenic modulation by the anti-human T-cell monoclonal antibody T101.

R. Dillman, I. Royston, D. Shawler, 1984, Cancer research.

A novel cell surface antigen (T305) found in increased frequency on acute leukemia cells and in autoimmune disease states.

R. Fox, S. Fong, S. Behar, 1983, Journal of immunology.

Chronic lymphocytic leukemia and other chronic lymphoid proliferations: surface marker phenotypes and clinical correlations.

R. Dillman, M. Green, I. Royston, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Epidermal growth factor receptor expression in human lung carcinomas defined by a monoclonal antibody.

J. Mendelsohn, I. Royston, H. Masui, 1987, Journal of the National Cancer Institute.

Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross-reactivity with an antigen on circulating cells.

R. Dillman, P. Hagan, R. Bartholomew, 1984, Cancer research.

Comparative mortality of childhood leukemia and lymphoma among the immigrants and native born in Israel

I. Royston, And Baruch Modan, 1968, Cancer.

Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukemia.

R. Dillman, I. Royston, D. Shawler, 1982, Blood.

This information is current as by Antigen Boost in the SCID Mouse Human Splenocytes : In Vitro Priming Followed Antigen-Specific IgG Responses from Naive and

P. R. Morrow, P. Brams, I. Royston, 1998 .

Antigen-specific IgG responses from naive human splenocytes: in vitro priming followed by antigen boost in the SCID mouse.

P. R. Morrow, P. Brams, I. Royston, 1998, Journal of immunology.

Structural characterization of the human T cell surface antigen (p67) isolated from normal and neoplastic lymphocytes.

R. Fox, J. Elder, I. Royston, 1982, Journal of immunology.

Genetically stable human hybridomas secreting tumor-reactive human monoclonal IgM.

C. Surh, I. Royston, M. Glassy, 1987, Cancer investigation.

Elevated serum chromogranin A concentrations in small-cell lung carcinoma.

D. O'Connor, L. Deftos, I. Royston, 1986, Annals of internal medicine.

Immunoincompetence in cancer patients. Assessment by in vitro stimulation tests and quantification of lymphocyte subpopulations

J. Koziol, R. Dillman, I. Royston, 1984, Cancer.

Lymphokine gene therapy of cancer

F. Gage, I. Royston, H. Fakhrai, 1990 .

Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study.

J. Koziol, D. Mercola, D. Gold, 1995, Human gene therapy.

Design and Production of Human Monoclonal Antibodies to Human Cancers

I. Royston, M. Glassy, H. Handley, 1985 .

A human monoclonal antibody reactive with human prostate.

I. Royston, M. Glassy, Joseph D. Schmidt, 1984, The Journal of urology.

UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas.

I. Royston, M. Glassy, H. Handley, 1983, Proceedings of the National Academy of Sciences of the United States of America.

An enzyme immunofiltration assay useful for detecting human monoclonal antibody.

P. Cleveland, I. Royston, M. Glassy, 1983, Journal of immunological methods.

Immunological Approaches for Gene Therapy of Cancer

D. Gold, R. Bartholomew, I. Royston, 1998 .

Monoclonal antibodies to a human T-cell antigen and Ia-like antigen in the characterization of lymphoid leukemia.

M. Omary, I. Trowbridge, I. Royston, 1981, Transplantation Proceedings.

Abstract 25: Whole genome sequencing and quantitative proteomics reveal HPV integration and HER2 overexpression in a patient with cervical cancer: Comprehensive omics analysis driving clinical treatment decisions

Charles J. Vaske, S. Benz, S. Rabizadeh, 2016 .

IDEC-C 2 B 8 ( Rituximab ) Anti-CD 20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin ’ s Lymphoma

D. Maloney, K. Foon, R. Schilder, 1997 .

Morphologic and cytochemical comparison of human lymphoblastoid T-cell and B-cell lines: light and electron microscopy.

C. Taylor, J. Parker, I. Royston, 1978, Journal of the National Cancer Institute.

Cell Surface Antigens on Normal and Neoplastic Human Lymphoid Cells

R. Fox, I. Royston, S. Baird, 1982 .

Utility of monoclonal antibodies in the immunologic phenotyping of acute lymphoblastic leukemia.

F. Kung, A. Yu, I. Royston, 1982, Hybridoma.

Establishment of a human B-cell tumor in athymic mice.

D. Johnson, R. Dillman, J. Leonard, 1987, Cancer research.

Infection of human and rhesus lymphoblastoid cells withHerpesvirus macaca

I. Royston, P. Graze, 2005, Archives of Virology.

Alterations of peripheral blood B‐lymphocyte populations in plasma cell disorders

R. Dillman, I. Royston, J. C. Griffiths, 1981, Cancer.

Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.

E. Perlin, J. Sullivan, I. Royston, 1975, The New England journal of medicine.

Radiolabeling of monoclonal antitumor antibodies: comparison of i-125 and in-111-anti-cea with ga-67 in a nude mouse-human colon tumor model. Abstr.

R. Dillman, I. Royston, G. David, 1981 .

Extensive disease small cell carcinoma of the lung. Trial of non‐cross resistant chemotherapy and consolidation radiotherapy

J. Koziol, J. Mendelsohn, R. Dillman, 1982, Cancer.

Alterations in cell surface phenotype of T- and B-cell chronic lymphocytic leukemia cells following in vitro differentiation by phorbol ester.

I. Royston, D. Shawler, M. Glassy, 1984, Journal of the National Cancer Institute.

antibodies Adult acute lymphoblastic leukemia phenotypes defined by monoclonal

C. Bloomfield, T. Lebien, J. Minowada, 2011 .

Phenotypes of Adult Acute Lymphoblastic Leukemia Defined by Monoclonal Antibodies

C. Bloomfield, T. Lebien, J. Minowada, 1984 .

Clinical Utility of Monoclonal Antibodies in the Phenotyping of Acute and Chronic Lymphocytic Leukemia

Mark R. Green, A. Yu, R. Dillman, 1983 .

Comparative density of the human T-cell antigen T65 on normal peripheral blood T cells and chronic lymphocytic leukemia cells.

I. Royston, S. Wormsley, M. Collins, 1981, Blood.

Colony-forming assay for circulating chronic lymphocytic leukemia cells.

R. Taetle, D. To, I. Royston, 1982, Leukemia research.

Applications and limitations of peripheral blood lymphocyte immunoglobulin light chain analysis in the evaluation of non‐Hodgkin's lymphoma

Mark R. Green, R. Dillman, J. Griffiths, 1985, Cancer.

Kinetics of protein synthesis inactivation in human T-lymphocytes by selective monoclonal antibody-ricin conjugates.

N. Kaplan, J. Leonard, I. Royston, 1985, Cancer research.

The association of genital herpesvirus with cervical atypia and carcinoma in situ.

L. Aurelian, I. Royston, 1970, American journal of epidemiology.

Expression of shared idiotypes in chronic lymphocytic leukemia and small lymphocytic lymphoma.

C. Bloomfield, R. Miller, I. Royston, 1991, Blood.

Autologous human B and T lymphoblastoid cell lines

E. Huang, J. Pagano, I. Royston, 1974, Nature.

Failure of cultured human T-cell lymphoid lines to stimulate in mixed leukocyte culture.

I. Royston, P. Graze, R. B. Pitts, 1974, Journal of the National Cancer Institute.

Factors affecting production of antibodies to prostate antigens by in vitro-primed human splenocytes.

P. Brams, I. Royston, E. Lu, 1993, Hybridoma.

Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: a Phase I study.

D. Carlo, D. Mercola, C. V. van Beveren, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Human autologous mixed lymphocyte reactivity is primarily specific for xenoprotein determinants adsorbed to antigen-presenting cells during rosette formation with sheep erythrocytes

M. Merkenschlager, C. Huber, I. Royston, 1982, The Journal of experimental medicine.

Immunofluorescent detection of herpesvirus antigens in exfoliated cells from human cervical carcinoma.

L. Aurelian, I. Royston, 1970, Proceedings of the National Academy of Sciences of the United States of America.

Antibody to genital herpes simplex virus: association with cervical atypia and carcinoma in situ.

L. Aurelian, H. J. Davis, I. Royston, 1970, Journal of the National Cancer Institute.

The use of monoclonal antibodies and flow cytometry to detect peripheral blood and bone marrow involvement of a diffuse, poorly differentiated lymphoma.

R. Dillman, I. Royston, S. Baird, 1985, International journal of immunopharmacology.

Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody.

D. Carson, S. Slovin, J. Vaughan, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Interleukin-2 gene therapy in a patient with glioblastoma.

J. Koziol, R. Gjerset, I. Royston, 1995, Gene therapy.

Monoclonal antibodies to purified ricin A-chain: production and properties.

J. Leonard, R. Taetle, I. Royston, 1987, Hybridoma.

IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

D. Maloney, K. Foon, R. Schilder, 1997 .

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.

D. Mercola, K. Black, H. Lin, 1996, Proceedings of the National Academy of Sciences of the United States of America.

The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B.

C. Schiffer, E. Henderson, R. Silver, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cytokine gene therapy with interleukin-2-transduced fibroblasts: effects of IL-2 dose on anti-tumor immunity.

J. Koziol, R. Naviaux, R. Gjerset, 1995, Human gene therapy.

Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia.

I Royston, C. Bloomfield, J. Griffin, 1987, The New England journal of medicine.

Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies.

C. Bloomfield, T. Lebien, J. Minowada, 1985, Blood.

In vitro lymphocyte dysfunction in Hodgkin's disease.

E. Perlin, I. Royston, P. Graze, 1976, Journal of the National Cancer Institute.

Establishment and Characterization of an Epstein-Barr Virus-negative Lymphoma B-Cell Line from a Patient with a Diffuse Large Cell Lymphoma

R. Dillman, I. Royston, H. Handley, 1982 .

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.

D. Maloney, J. Rosenberg, C. White, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma.

I Royston, D. Maloney, K. Foon, 1997, Blood.

Shared idiotypes expressed by human B-cell lymphomas.

D. Czerwinski, R. Miller, I. Royston, 1989, The New England journal of medicine.

Radioimmunotherapy of human B-cell lymphoma with 90Y-conjugated antiidiotype monoclonal antibody.

R. Miller, Mark R. Green, B. Parker, 1990, Cancer research.

Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody.

R. Dillman, I. Royston, D. Shawler, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Morphologic and cytochemical characterization of adult lymphoid leukemias which express myeloid antigen.

C. Bloomfield, R. Mick, F. Davey, 1988, Leukemia.

Human T-cell antigens defined by monoclonal antibodies. Absence of T65 on committed myeloid and erythroid progenitors

R. Taetle, I. Royston, 1980 .

Human T-cell antigens defined by monoclonal antibodies. Absence of T65 on committed myeloid and erythroid progenitors.

R. Taetle, I. Royston, 1980, Blood.

Development of a rapid microELISA assay for screening hybridoma supernatants for murine monoclonal antibodies.

P. Cleveland, I. Royston, M. Glassy, 1982, Journal of immunological methods.

Combination of transforming growth factor beta antisense and interleukin-2 gene therapy in the murine ovarian teratoma model.

J. Berek, I. Royston, O. Dorigo, 1998, Gynecologic oncology.

Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: a Cancer and Leukemia Group B study.

R. Weiss, F. Millard, F. Davey, 1993, Blood.

Phase I Trials of Murine Monoclonal Antibodies to Tumor Associated Antigens: Preliminary Observations

R. Dillman, I. Royston, R. Sobol, 1982 .

Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukemia

R. Dillman, I. Royston, D. Shawler, 1982 .

Cell mediated immunity during infectious mono‐nucleosis to epstein‐barr virus associated antigens

P. Levine, I. Royston, D. Ablashi, 1977, International journal of cancer.

Results of Early Trials Using Murine Monoclonal Antibodies as Anticancer Therapy

R. Dillman, I. Royston, D. Shawler, 1983 .

Plasma calcitonin as a marker of disease activity in patients with small cell carcinoma of the lung.

S. Wallach, L. Deftos, R. Taetle, 1981, The Journal of clinical endocrinology and metabolism.

Chronic lymphocytic leukemia progenitor cells carry the antigens T65, BA-1, and Ia.

N. Kay, T. Lebien, I. Royston, 1983, Blood.

Letter: Epstein-Barr virus and infectious mononucleosis.

I. Royston, 1973, Lancet.

Radioimmunotherapy of relapsed B-cell lymphoma with yttrium 90 anti-idiotype monoclonal antibodies.

R. Miller, B. Parker, C. White, 1996, Blood.

Characterization of a new human glioblastoma cell line that expresses mutant P53 and lacks activation of the PDGF pathway

D. Mercola, S. Wen, Hong Lin, 1995, In Vitro Cellular & Developmental Biology - Animal.

Immunophenotyping in the diagnosis and classification of acute lymphoblastic leukemia.

C. Bloomfield, I. Royston, R. Sobol, 1988, Clinics in laboratory medicine.

Non-cross-resistant chemotherapy and consolidation radiotherapy for small cell carcinoma of the lung.

R. Dillman, S. Seagren, M. Green, 1982, Cancer treatment reports.

Unique subset of thymic epithelial cells defined by the expression of a novel neuroendocrine antigen.

L. Deftos, I. Royston, R. Sobol, 1988, Cellular immunology.

Production of antigen-specific human monoclonal antibodies from in vitro-primed human splenocytes.

P. Brams, P. Boerner, I. Royston, 1991, Journal of immunology.

Comparison of gene therapy with interleukin-2 gene modified fibroblasts and tumor cells in the murine CT-26 model of colorectal carcinoma.

R. Gjerset, I. Royston, O. Dorigo, 1995, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Homogeneous antibodies directed against human cell surface antigens: I. The mouse spleen fragment culture response to T and B cell lines derived from the same individual.

L. Lampson, I. Royston, R. Levy, 1977, Journal of supramolecular structure.

Strategies for the design and use of tumor‐reactive human monoclonal antibodies

S. Gaffar, I. Royston, M. Glassy, 1986, BioEssays : news and reviews in molecular, cellular and developmental biology.

Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study

Patricia A. Young, D. Faller, P. Scheinberg, 2023, Blood advances.

Membranous nephropathy associated with an unusual phenotype of chronic lymphocytic leukemia

R. Dillman, C. White, I. Royston, 1983, Cancer.

Techniques for Characterization of Leucocyte Antigens and Utilization of Antibodies in Therapy

H. Tanke, J. Ploem, K. Lennert, 1984 .